Atossa Therapeutics, Inc.

ATOS forming into a potential revival pattern, possible buy

188
ATOS has been trading sideways for the better part of a month showing little move in volume and no strong RSI pull to the bullish or bearish side. Recently it has exhibited an increase in volume that may be due to the recent arrival of their new scientific advisor Dr. Cal Novina. Moreover, on the 15th of November (Marked with an arrow) the CFO of the company, Guse Kyle, decided to buy a combined 10,000 shares. This could be due to a potential plan that is in the making and/or new insight on the direction that the company might want to go. Moreover, the MACD analysis (marked with a circle) shows the MACD line and the signal line converging sometime in the near future triggering a possible buy point. In addition, the RSI indicator seems to be gaining speed and rising at a quick rate. I have marked with a yellow line the potential pattern that we might be seeing in the coming days. Also, over the past two days, the stock has been trading above the 13EMA, falling to re-test it twice and it acting as a strong support and bouncing the stock back up. The stock seems to be forming a revival pattern and it looks like a potential long-term stock. I would not recommend buying until it has begun to form an ascending triangle.

면책사항

해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.